tsiproteroniasetaatti

Tsiproteroniasetaatti is a synthetic, non-steroidal androgen and anabolic steroid. It is a derivative of 17-alpha-methyltestosterone, with the addition of a cyano group at the 17-alpha position and an acetate ester at the 17-beta position. This compound was first synthesized in the early 1960s and has since been used in both medical and recreational contexts.

In medical settings, tsiproteroniasetaatti has been studied for its potential benefits in treating conditions such as hypogonadism, a condition characterized by low testosterone levels. It has also been explored for its anabolic effects, which can help in muscle growth and strength enhancement. However, its use in medical practice is limited due to its potential side effects and the availability of more effective and safer alternatives.

Recreational use of tsiproteroniasetaatti is common among athletes and bodybuilders due to its potent anabolic properties. It is often used in cycles to promote muscle mass, strength, and endurance. However, its use is controversial and can lead to serious health risks, including liver toxicity, cardiovascular issues, and hormonal imbalances.

Tsiproteroniasetaatti is typically administered via oral ingestion or intramuscular injection. Its effects are generally felt within a few hours of administration, with peak levels occurring within 4-6 hours. The duration of its effects can vary, but it is generally considered to have a moderate to long half-life.

Due to its potential for abuse and the associated health risks, tsiproteroniasetaatti is classified as a controlled substance in many countries. Its use is regulated to prevent misuse and ensure that it is only used under medical supervision when necessary.